{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:17:15Z","timestamp":1789514235737,"version":"build-2803163510"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1097\/cld.0000000000000228","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T17:01:09Z","timestamp":1718211669000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Should we expand treatment initiation criteria for chronic HBV infection: Pros"],"prefix":"10.1097","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-7596","authenticated-orcid":false,"given":"Chih-Lin","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Renai Branch, Taipei City Hospital, Taipei, Taiwan"},{"name":"Department of Psychology, National Chengchi University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-7952","authenticated-orcid":false,"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medicine, National Taiwan University, College of Medicine, Taipei, Taiwan"},{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Hepatitis Research Center, and Department of Medical Research, National Taiwan University, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"R1-20241015","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"R2-20241015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/apt.17272","article-title":"Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone","volume":"57","author":"Wang","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"R3-20241015","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3748\/wjg.v29.i16.2479","article-title":"Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication","volume":"29","author":"Jiang","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R4-20241015","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","article-title":"Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase","volume":"20","author":"Huang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-20241015","doi-asserted-by":"crossref","first-page":"1226755","DOI":"10.3389\/fcimb.2023.1226755","article-title":"The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: A systematic review and meta-analysis","volume":"13","author":"Liu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R6-20241015","doi-asserted-by":"crossref","first-page":"748","DOI":"10.14309\/ajg.0000000000001691","article-title":"Hepatitis B core-related antigen stratifies the risk of liver cancer in HBeAg-negative patients with indeterminate phase","volume":"117","author":"Tseng","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R9-20241015","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/HEP.0000000000000459","article-title":"Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase","volume":"78","author":"Huang","year":"2023","journal-title":"Hepatology"},{"key":"R10-20241015","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/apt.16097","article-title":"East Asia expert opinion on treatment initiation for chronic hepatitis B","volume":"52","author":"Kao","year":"2020","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CLD.0000000000000228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T18:08:23Z","timestamp":1732212503000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CLD.0000000000000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cld.0000000000000228","relation":{},"ISSN":["2046-2484"],"issn-type":[{"value":"2046-2484","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-11-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}